IL

Indica Labs Company Overview and Market Research Report



Company Overview



Name: Indica Labs, Inc.


Mission: Transform tissue-based research and diagnostics with computational pathology and AI.



Company Details:


  • Founded: 2011

  • Founder/CEO: Steven Hashagen

  • Headquarters: Albuquerque, New Mexico, USA

  • Number of Employees: No information is available

  • Revenue: No information is available

  • Known for: AI-powered digital pathology software and services


Key People:


  • Steven Hashagen, Founder and CEO

  • Eric Runde, COO


Products



Indica Labs offers a range of digital pathology products designed to integrate AI and deep learning for various diagnostic and research applications.

HALO® Platform


High-Level Description:


HALO® is a comprehensive image analysis platform designed for tissue-based research applications. It supports quantitative analysis, collaboration, and data management in pathology.

Key Features:


  • Quantitative evaluation of whole slide images

  • Integration of AI and deep learning algorithms

  • Customizable for different research and diagnostic needs


HALO AI®


High-Level Description:


An extension of the HALO platform focusing specifically on AI-powered image analysis.

Key Features:


  • Pre-trained tissue classifiers and cell phenotypers

  • Customizable and trainable with customer data

  • Integration with other HALO modules


HALO AP® and HALO AP Dx


High-Level Description:


Digital pathology platforms for primary diagnosis, suitable for use in clinical and research environments.

Key Features:


  • FDA clearance for primary diagnosis (HALO AP Dx)

  • CE-IVDR marked for in-vitro diagnostic use

  • Facilitates remote work and consultations


HALO Link®


High-Level Description:


A collaborative image management platform designed for research pathology labs.

Key Features:


  • Browser-based interface for image sharing and collaboration

  • System-wide auditing and compliance features

  • Seamless integration with HALO and HALO AI


HALO Clinical AI Solutions


Examples Include:


1. HALO Prostate AI
  • CE-IVD certified tool for detection and Gleason grading of prostate cancer.

2. Lung PD-L1 AI
  • AI-based tool for scoring PD-L1 IHC in NSCLC.

3. Breast IHC AI
  • AI-based decision-support tool for HER2, ER, PR, and Ki67 IHC.

4. Lung Macrodissect AI
  • AI-powered tool to streamline tumor annotation and enhance molecular analysis.


Recent Developments



New Product Launches:


1. HALO AI Apps - Pre-trained tissue classifiers and cell phenotypers for life sciences, launched in August 2024.
2. Lung Macrodissect AI - Launched in August 2024 to improve molecular pathology workflows by quantifying tumor content and guiding ROI selection.
3. HALO AP Dx - Received FDA 510(k) clearance in May 2024, enabling primary diagnosis in the US with the Hamamatsu NanoZoomer® S360MD Slide scanner.

Enhanced Features:


  • Integration of AI membrane segmentation in the Highplex FL and FISH-IF modules, improving analysis speed and accuracy.

  • Development of HALO Link Compliance Add-on to support auditing in research pathology laboratories.


Strategic Partnerships:


1. Paige - Non-exclusive partnership with Paige, integrating Paige’s diagnostic AI models into the HALO AP® platform to enhance pathology workflows (August 2024).
2. Lunit - Agreement for a fully interoperable solution between Indica Labs’ HALO AP® and Lunit’s suite of AI pathology products (April 2023).

Expansion:


  • Expanded reseller network in the Asia Pacific region, specifically the Philippines, Thailand, Vietnam, and Malaysia (July 2024).


Industry Recognition and Events:


  • Announcement of the Indica Labs’ Bay Area HALO® 2024 User Group Meeting to be held on October 16, 2024.

  • Webinar initiatives such as "Introducing HALO AI Apps for the Life Sciences” and “AI-Powered Image Analysis of HCR™ RNA-ISH Assays”.


Compliance and Certifications:


  • HALO AP Dx is FDA-cleared in the US.

  • HALO AP® and HALO AP Dx have CE-IVDR marking for primary diagnosis in the EU, UK, and Switzerland.

  • HALO AP® platform includes built-in compliance with FDA 21 CFR Part 11, HIPAA, and GDPR.


Conclusion


Indica Labs stands out as a leader in AI-driven digital pathology solutions, offering robust platforms for both clinical and research applications. Their commitment to innovation, coupled with strong strategic partnerships and compliance with international standards, positions them as a pivotal player in enhancing diagnostic accuracy and efficiency.